It appears to me that the weakness is due to concerns in the market that revenue and ongoing revenue growth is less visible than in the last year. With the high dividend payout there is probably less room for an acquisition at least this half so all growth needs to be organic.
That said if RXP executes well (and no reason to think they won't) this will be worth much more in 1, 2 or 3 years time.